University of California San Francisco
Give to UCSF
Displaying 151 - 180 of 513
-
-
LSD-Like Molecules Counter Depression Without the Trip
Scientists have designed compounds that hit the same key receptor that LSD activates without causing hallucinations. A single dose produced powerful antidepressant and antianxiety effects in mice that lasted up to two weeks.
-
Drug Turns Cancer Gene Into ‘Eat Me’ Flag for Immune System
A new therapy pulls forward a mutated version of the KRAS protein to help the immune system recognize and destroy cancer cells.
-
Pregnant Women Exposed to Cancer-Causing Chemicals in Dishware, Hair Coloring, Plastics, and Pesticides
Pregnant women in the U.S. are being exposed to chemicals like melamine, cyanuric acid, and aromatic amines that can increase the risk of cancer and harm child development, according to a study from researchers at UCSF and Johns Hopkins Bloomberg School of Public Health.
-
A.I. Predicts the Shape of Nearly Every Protein Known to Science
-
When Are Expired Drugs Truly Expired?
-
New Documents Show McKinsey’s Role in Opioid Epidemic
The Opioid Industry Documents Archive (OIDA), a project of UCSF, and Johns Hopkins University, today released more than 114,000 documents related to McKinsey & Company's work as a management consulting firm for the opioid industry.
-
The Nobel-Winning Discoveries Illuminating How We Sense the World
How David Julius and Ardem Patapoutian found the molecules in our bodies that sense heat, cold, touch, and pain – and transformed sensory neuroscience.
-
UCSF Cancer Specialists to Present Clinical Findings at Major Conference
The latest advances in cancer care and research will be showcased at the annual American Society of Clinical Oncology (ASCO) Annual Meeting, the world’s largest clinical cancer meeting.
-
Using Antibiotics To Prevent STIs Found Effective in Early S.F. Study Results
-
Doxycycline After Unprotected Sex Significantly Reduced STIs
A significant proportion of bacterial sexually transmitted infections – gonorrhea, chlamydia, or syphilis – were prevented with a dose of doxycycline after unprotected sex, according to preliminary results of a clinical trial.
-
UCSF Readying Itself to Tackle Future Pandemics
-
Opioid Industry Archive Releases 1.4M Documents from Leading Opioid Maker Implicated in Drug Crisis
UCSF and Johns Hopkins University announced the addition of 1.4 million documents to their Opioid Industry Documents Archive from Mallinckrodt, a leading generic opioid manufacturer now in bankruptcy.
-
COVID Drug May Also Ease Symptoms of Long COVID
An antiviral drug approved for high-risk COVID patients may also benefit those with long COVID, according to the findings of a small case series that need to be confirmed with future rigorous studies.
-
Evidence Mounts for Need To Study Pfizer’s Paxlovid for Long COVID - Researchers Say
-
How the Discovery of an Alzheimer’s Tipping Point Could Improve Drug Trials
In a study, UCSF neurologist William Seeley, MD, and colleagues identified two key moments in the natural history of Alzheimer’s, pointing to a window of opportunity for treatment with amyloid-lowering drugs.
-
Seniors with Memory Issues Take Multiple Medications, but Most Are Willing to Cut Down
55% of seniors with dementia take more than six medications even though most have good health. However, a UCSF study showed that 87% are willing to cut down if their doctors agree.
-
Treating Tough Tumors by Exploiting Their Iron ‘Addiction’
UCSF researchers successfully leveraged an FDA-approved drug to halt growth of tumors driven by mutations in the RAS gene, which are famously difficult to treat and account for about one in four cancer deaths.
-
Solving the Mystery of a Stubborn – and Common – Cancer Gene
Mark Moasser, MD, has sorted out why HER2, the protein driving 1 in 5 breast cancers, is so hard to drug. He explains how the findings correct a naive way of envisioning how HER2 is shaped and how it works.
-
Immune Cells Leave Fingerprints on Tumors Metastasized to the Brain, Offering Clues to Future Therapies
Using data from over 100,000 malignant and non-malignant cells from 15 human brain metastases, UCSF researchers have revealed two functional archetypes of metastatic cells across 7 different types of brain tumors, each containing both immune and non-immune cell types.
-
Drug Offers New Hope to Select Patients with ALS, UCSF-CPMC Study Shows
A UCSF-led study found a new drug for ALS that shows to slow or temporarily stall the progression of ALS in a select group of patients, with three times as many patients' disease slowing compared to those who received a placebo.
-
Human Proteins Behind COVID-19 Infection Revealed by Innovative CRISPR Technology
In the quest for new treatments for COVID-19, a team led by UCSF researchers identified a new potential drug target that may prevent infection of human cells by SARS-CoV-2.
-
As Omicron Surges, UCSF Experts Answer Questions About the COVID-19 Variant
There is some information that is known about the variant and other information that sti
-
International Breast Cancer Conference Features UCSF Health Experts
Image Helen Diller Family Cancer Research Building Experts from UCSF Health will present new research and clinical findings at the annual San
-
Looking to the Cell’s Power Generators for Clues to Depression
Hoping to discover a new approach to treating depression, UCSF researchers looked at mitochondrial proteins and found that people with untreated depression have significantly lower levels of these proteins. New hypotheses emerge about the relationship between depression and the function of the brain’s energy-hungry neurons.
-
New Study Indicates Fluvoxamine, an Anti-depressant Pill, Could Help Reduce Hospitalizations
-
COVID Patients on SSRI Antidepressants Are Less Likely to Die, UCSF-Stanford Study Finds
A UCSF and Stanford study of electronic health records linked SSRIs, the most widely prescribed antidepressants, to survival for COVID-19 patients.
-
UCSF Rises in US News Global Universities Rankings for 2022
UCSF’s research has been ranked among the top in the world, according to the latest U.S. News & World Report’s Best Global Universities 2022 rankings.
-
How Cells Multitask: The Magic of Molecular Switches
Researchers at UCSF’s Quantitative Biosciences Institute (QBI) have observed how molecular switches regulate many different biological processes simultaneously. Their findings may shed light on how disease mutations operate, offering new ways to target malfunctioning switches and prevent illness.
-
Scientists Map Brain Circuit that Drives Activity in Fertile Females
A team of UCSF scientists have identified the specific neurons and signaling pathway that make sexually receptive females of many species more active at the time of ovulation.
